Navigation Links
Xenon Receives a Milestone Payment for Marketing Approval of Glybera in Europe
Date:2/5/2013

VANCOUVER, British Columbia, Feb. 5, 2013 /PRNewswire/ -- Xenon, a clinical stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced that it has received a milestone payment from uniQure BV for the European Commission marketing approval of Glybera®, a novel gene therapy treatment for the orphan disease lipoprotein lipase deficiency (LPLD), and the first gene therapy approved in the Western world.

Xenon exclusively licensed to uniQure BV its rights to the LPLS447X genetic variant that causes a gain of function in the lipoprotein lipase (LPL) gene in humans.  Humans with the LPLS447X variant have been shown on average to have lower triglyceride and higher HDL cholesterol levels than those without LPLS447X.  Glybera developed by uniQure is an adeno-associated virus based human gene therapy that contains LPLS447X and in clinical studies Glybera was effective in reducing blood fat levels and episodes of pancreatitis in patients with LPLD.

"The approval of Glybera is an important milestone for our Company and for the gene therapy field in general," said Simon Pimstone , President and CEO of Xenon. "Xenon was founded with a commitment to advancing human genetic discoveries into novel therapies for difficult to treat orphan diseases and Glybera is the first product to be marketed by one of our licensees."

In addition to the milestone payment Xenon is also entitled to receive from uniQure BV royalty payments on sales of Glybera, which is expected to start selling in Europe in 2013. The LPLS447X technology in Glybera was conceived and developed by Xenon's former CSO Michael Hayden at the Center of Molecular Medicine, University of British Columbia.

About Xenon Pharmaceuticals Inc. (Xenon)

Xenon is a privately owned, clinical genetics-bas
'/>"/>

SOURCE Xenon Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
2. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
3. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
4. Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
5. Carnegies Wolf B. Frommer receives Bogorad Award for Excellence in Plant Biology
6. UC Riverside plant cell biologist receives top scientific honor
7. UC Riverside receives grant for global health and development research
8. Washington University receives $8 million to lead international childhood malnutrition effort
9. SRI Sarnoffs Iris on the Move® N-Glance™ Identification System Receives Lenel Factory Certification
10. SF State biology department receives $1.5 million to support science teaching
11. Dr. Karen Lloyd receives WHOIs Holger W. Jannasch Visiting Scholar Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 15, 2015  BellBrook Labs, a leader in high ... launch of a TR-FRET (time resolved Forster resonance ... Assay, a high throughput screening assay for glycosyltransferases ... allow for sensitive detection of hundreds of human ...
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
(Date:1/22/2015)... N.C. , Jan. 22, 2015 Infinisource has launched ... of the G2 model. The G2 sets a higher standard ... iSolved human capital management solution. With plug-and-play installation, touch screen ... time clock provides a robust time collection solution for the ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Infinisource's NXG series sets new time clock standard 2
... Micro-organisms occurring naturally in coastal mudflats have an essential ... down petrochemical residues. Research by Dr Efe Aganbi and ... Society for General Microbiology,s meeting at Harrogate today (Monday ... degradation of the chemicals depending on whether or not ...
... 12-year-old Dutch boy bedridden for three years because ... join his friends on the soccer field thanks to ... , The investigators, led by Bjrn Knollmann, M.D., Ph.D., ... the clinically available drug flecainide prevents potentially lethal arrhythmias ...
... in Nature , researchers at Brandeis University and the ... time shed light on a crucial step in the complex ... in the human cell and frequently at which point genetic ... they were able to crystallize a very large complex of ...
Cached Biology News:Microbes in mud flats clean up oil spill chemicals 2Targeted drug therapy prevents exercise-induced arrhythmias 2Targeted drug therapy prevents exercise-induced arrhythmias 3A splice of life 2
(Date:2/26/2015)... PA (PRWEB) February 26, 2015 ... 9 -12, at the Ernest N. Morial Convention ... exhibitors (count as of February 19, 2015) displaying ... in industrial, academic, and government labs. The Exposition ... as, but not limited to, analytical chemistry; drug ...
(Date:2/26/2015)... 26, 2015 Innovation is more ... from unexpected parts of the world and transforming ... agriculture to manufacturing to health care, disruption is ... realities and socio-political trends shake the foundations of ... ingredient for CEOs to survive the next wave ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Regis ... for the development of oncology drug substances. , Regis ... up of their new Potent Compound Suite (PCS) for ... a 36,000 square foot, cGMP facility in Morton Grove, ... cGMP manufacturing of potent compounds up to about one ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Regis Extends cGMP Services to Oncology Market 2
... Directors, EXTON, Pa., Nov. 5 Isolagen(TM), Inc. ... Meeting of,Stockholders, held today in Exton, Pennsylvania. Stockholders ... new Director.,Dr. Selzer has been a partner with the ... Selzer has been executive director,of the Hallowell-West Medical Center, ...
... Nov. 5 deCODE genetics,(Nasdaq: DCGN ) today ... 30, 2007. A conference call to discuss the,quarter,s results ... November 6, at 8:00am Eastern Standard Time/1pm GMT,(details below). ... 2007 was $24.2 million,compared to $23.6 million for the ...
... Will be Core Application for ... Wellness Programs, WASHINGTON, Nov. 5 Netsmart ... services for health and,human services organizations, today announced ... health software and provide related services to the,Detroit ...
Cached Biology Technology:Isolagen, Inc. Reports Results of Shareholders Annual Meeting 2Isolagen, Inc. Reports Results of Shareholders Annual Meeting 3deCODE genetics Announces Third Quarter 2007 Financial Results 2deCODE genetics Announces Third Quarter 2007 Financial Results 3deCODE genetics Announces Third Quarter 2007 Financial Results 4deCODE genetics Announces Third Quarter 2007 Financial Results 5deCODE genetics Announces Third Quarter 2007 Financial Results 6deCODE genetics Announces Third Quarter 2007 Financial Results 7deCODE genetics Announces Third Quarter 2007 Financial Results 8deCODE genetics Announces Third Quarter 2007 Financial Results 9Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software 2
... Radiant Red fluorescent RNA stain is ... denaturing (formaldehyde or glyoxal) agarose gels and ... excitation with a 302 nm transilluminator, the ... be photographed on Polaroid film or with ...
... costs. More efficient interfacing with mass ... volumes. Industry demands for benefits like ... chromatography for routine applications. Standard HPLC ... the need to operate with smaller ...
From the company that first brought you the chromatin immunoprecipitation (ChIP) kit, a new and improved kit, EZ-ChIP, is now available to make your experiments easier, quicker, and most importantly,...
... for the PDS-1000 He biolistic system enables 7-10 ... standard system. It fits into the shocking chamber ... the helium shock wave over 7 microcarriers. By ... over this larger area, the system maximizes the ...
Biology Products: